Home Tags Regeneron

Tag: Regeneron

UPDATE: Greenburgh Planning Board leaning toward approval of $450M Regeneron project

Pharmaceutical giant Regeneron went back before the Greenburgh Planning Board Wednesday night as the town considers its application for a $450 million project. It...

Regeneron’s Covid cocktail receives updated FDA authorizations

REGEN-COV is readily available and supplied free of charge by the U.S. government.

13 Fairfield and Westchester companies make the Fortune 500

Walmart took the top spot for the ninth consecutive year.

Regeneron calculates $260M in 1Q antibody cocktail sales to government

Tarrytown-based Regeneron reports that it anticipates recording approximately $260 million in sales of its antiviral monoclonal antibody cocktail REGEN-COV U.S. to the U.S. government for the first quarter of 2021. Continuing deliveries...

Regeneron proposes 207,000 sf lab on Greenburgh campus

Regeneron is working on plans for the construction of an approximately 207,000-square-foot laboratory building and associated parking garage on the company's existing campus at...

UnitedHealthcare Insurance accuses Regeneron of kickbacks to inflate Eylea price

“Regeneron set Eylea’s price well beyond what the market would otherwise bear,” the complaint states, and left Medicare plan sponsors like United “to foot the large majority of the inflated bill.”

Regeneron sues U.S. to stop Medicare drug pricing rule

Trump has called the new rule “groundbreaking” and declared that it will “transform the way the U.S. government pays for drugs.” Regeneron argues that price controls will discourage investments in new drugs and could lead to drug shortages.

Regeneron gets FDA approval for antibody cocktail to fight Covid-19

Tarrytown-based Regeneron has received an emergency use authorization from the U.S. Food and Drug Administration allowing use of its REGEN-COV2 antibody cocktail for the...

Westfair Businesspersons of the Year: Regeneron’s Leonard Schleifer and George Yancopoulos

The Tarrytown-based company has gone from being a tiny 1988 startup to a $50 billion market-cap business.

Regeneron’s Ebola treatment granted FDA approval

Inmazeb is a mixture of three monoclonal antibodies and was designed to treat Zaire ebolavirus. It is the first FDA-approved treatment for Ebola virus infection in adult and pediatric patients.

Regeneron facing patent infringement suit over Covid-19 treatment

Regeneron Pharmaceuticals is one of three pharma companies that stand accused of patent infringement, in lawsuits alleging the unlawful use of a technology used...

President Trump receives Regeneron Covid drug

White House Physician Sean P. Conley in a memorandum prepared for White House Press Secretary Kayleigh McEnany, has revealed that President Donald Trump has...

Regeneron strikes deal with Roche on Covid cocktail

The cocktail is needed to both protect against being infected by the Covid-19 virus and also provide a treatment should infection occur.

Regeneron receives $450M federal contract for its potential coronavirus cocktail

Regeneron Pharmaceuticals has received a $450 million contract from the federal government to manufacture and supply REGN-COV2, its investigational treatment of COVID-19. The double antibody...

Regeneron begins first human clinical trials of COVID-19 antibody ‘cocktail’

Regeneron this morning announced starting the first human clinical trial of a so-called “cocktail” of antibodies to fight COVID-19. The drug combination uses the...